advertisement

WGC-2027

Supuran CT 10

Showing records 1 to 10 | Display all abstracts from Supuran CT

125791 Polypharmacology of carbonic anhydrase inhibitors and activators
Bonardi A
Expert Opinion in Pharmacotherapy 2025; 26: 567-580
125420 Carbonic anhydrase inhibitors: Structural insights and therapeutic potential
Singh P
Bioorganic chemistry 2025; 156: 108224
126025 Design, Synthesis, and In Vitro Evaluation of Aromatic Sulfonamides as Human Carbonic Anhydrase I, II, IX, and XII Inhibitors and Their Antioxidant Activity
Abha Mishra KM
Journal of biochemical and molecular toxicology 2025; 39: e70135
125791 Polypharmacology of carbonic anhydrase inhibitors and activators
Supuran CT
Expert Opinion in Pharmacotherapy 2025; 26: 567-580
125420 Carbonic anhydrase inhibitors: Structural insights and therapeutic potential
Arifuddin M
Bioorganic chemistry 2025; 156: 108224
126025 Design, Synthesis, and In Vitro Evaluation of Aromatic Sulfonamides as Human Carbonic Anhydrase I, II, IX, and XII Inhibitors and Their Antioxidant Activity
Kumari N
Journal of biochemical and molecular toxicology 2025; 39: e70135
125420 Carbonic anhydrase inhibitors: Structural insights and therapeutic potential
Supuran CT
Bioorganic chemistry 2025; 156: 108224
126025 Design, Synthesis, and In Vitro Evaluation of Aromatic Sulfonamides as Human Carbonic Anhydrase I, II, IX, and XII Inhibitors and Their Antioxidant Activity
Carta F
Journal of biochemical and molecular toxicology 2025; 39: e70135
125420 Carbonic anhydrase inhibitors: Structural insights and therapeutic potential
Nerella SG
Bioorganic chemistry 2025; 156: 108224
126025 Design, Synthesis, and In Vitro Evaluation of Aromatic Sulfonamides as Human Carbonic Anhydrase I, II, IX, and XII Inhibitors and Their Antioxidant Activity
Renzi G; Supuran CT; Sethi KK
Journal of biochemical and molecular toxicology 2025; 39: e70135

Issue 25-2

Change Issue


advertisement

WGA Rescources